These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3971003)

  • 1. Carbamazepine-induced reduction of blood levels of haloperidol in chronic schizophrenia.
    Kidron R; Averbuch I; Klein E; Belmaker RH
    Biol Psychiatry; 1985 Feb; 20(2):219-22. PubMed ID: 3971003
    [No Abstract]   [Full Text] [Related]  

  • 2. Do enzyme inducers modify haloperidol decanoate rate of release?
    Pupeschi G; Agenet C; Levron JC; Barges-Bertocchio MH
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):1323-32. PubMed ID: 7863019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant dose effect of carbamazepine on reduction of steady-state plasma concentration of haloperidol in schizophrenic patients.
    Yasui-Furukori N; Kondo T; Mihara K; Suzuki A; Inoue Y; Kaneko S
    J Clin Psychopharmacol; 2003 Oct; 23(5):435-40. PubMed ID: 14520118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between carbamazepine and bromperidol.
    Otani K; Ishida M; Yasui N; Kondo T; Mihara K; Suzuki A; Furukori H; Kaneko S; Inoue Y
    Eur J Clin Pharmacol; 1997; 52(3):219-22. PubMed ID: 9218929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The drug-drug interaction effects of haloperidol on plasma carbamazepine levels.
    Iwahashi K; Miyatake R; Suwaki H; Hosokawa K; Ichikawa Y
    Clin Neuropharmacol; 1995 Jun; 18(3):233-6. PubMed ID: 8635181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study.
    Klein E; Bental E; Lerer B; Belmaker RH
    Arch Gen Psychiatry; 1984 Feb; 41(2):165-70. PubMed ID: 6365015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms?
    Arana GW; Goff DC; Friedman H; Ornsteen M; Greenblatt DJ; Black B; Shader RI
    Am J Psychiatry; 1986 May; 143(5):650-1. PubMed ID: 3963258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood levels of haloperidol in schizophrenic patients.
    Shvartsburd A; Dekirmenjian H; Smith RC
    J Clin Psychopharmacol; 1983 Feb; 3(1):7-12. PubMed ID: 6833528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of carbamazepine on plasma haloperidol levels.
    Jann MW; Ereshefsky L; Saklad SR; Seidel DR; Davis CM; Burch NR; Bowden CL
    J Clin Psychopharmacol; 1985 Apr; 5(2):106-9. PubMed ID: 3988968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine augmentation of haloperidol in chronic schizophrenia.
    Shim JC; Kelly DL; Kim YH; Yoon YR; Park JH; Shin JG; Conley RR
    J Clin Psychopharmacol; 2003 Oct; 23(5):520-2. PubMed ID: 14520132
    [No Abstract]   [Full Text] [Related]  

  • 11. RBC and plasma levels of haloperidol and clinical response in schizophrenia.
    Smith RC; Vroulis G; Shvartsburd A; Allen R; Lewis N; Schoolar JC; Chojnacki M; Johnson R
    Am J Psychiatry; 1982 Aug; 139(8):1054-6. PubMed ID: 7091432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to Iwashashi: "significantly higher plasma haloperidol level during cotreatment with carbamazepine may herald cardiac change".
    Zuiderwijk PB; Lavrijsen K
    Clin Neuropharmacol; 1997 Apr; 20(2):179. PubMed ID: 9099473
    [No Abstract]   [Full Text] [Related]  

  • 13. Doubleblind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol.
    Möller HJ; Kissling W; Riehl T; Bäuml J; Binz U; Wendt G
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):127-36. PubMed ID: 2664882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical state, plasma levels of haloperidol and prolactin: a correlation study in chronic schizophrenia.
    Rao VA; Bishop M; Coppen A
    Br J Psychiatry; 1980 Dec; 137():518-21. PubMed ID: 7214106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood levels of haloperidol and clinical outcome in schizophrenia.
    Doddi S; Rifkin A; Karajgi B; Cooper T; Borenstein M
    J Clin Psychopharmacol; 1994 Jun; 14(3):187-95. PubMed ID: 8027415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of plasma concentrations of haloperidol after the addition of fluoxetine.
    Goff DC; Midha KK; Brotman AW; Waites M; Baldessarini RJ
    Am J Psychiatry; 1991 Jun; 148(6):790-2. PubMed ID: 2035723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between plasma haloperidol concentrations and clinical results.
    Palao DJ; Araúxo A; Haro JM; Brunet M; Bernardo M
    Arch Gen Psychiatry; 1996 Dec; 53(12):1167-9. PubMed ID: 8956684
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship of serum haloperidol levels to clinical response in schizophrenic patients.
    Magliozzi JR; Hollister LE; Arnold KV; Earle GM
    Am J Psychiatry; 1981 Mar; 138(3):365-7. PubMed ID: 7468835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haloperidol pharmacokinetics following gastric bypass surgery.
    Fuller AK; Tingle D; DeVane CL; Scott JA; Stewart RB
    J Clin Psychopharmacol; 1986 Dec; 6(6):376-8. PubMed ID: 3805335
    [No Abstract]   [Full Text] [Related]  

  • 20. Haloperidol and thioridazine drug levels and clinical response in schizophrenia: comparison of gas-liquid chromatography and radioreceptor drug level assays.
    Smith RC; Baumgartner R; Burd A; Ravichandran GK; Mauldin M
    Psychopharmacol Bull; 1985; 21(1):52-8. PubMed ID: 3983338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.